Epidemiology of HIV infection in the United States: Implications for linkage to care

Clinical Infectious Diseases

Volumn 52, Issue SUPPL. 2, 2011, Pages

  Moore, Richard D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE; ARTICLE; AWARENESS; CD4 LYMPHOCYTE COUNT; DEMOGRAPHY; DRUG USE; EARLY DIAGNOSIS; EARLY INTERVENTION; ETHNICITY; GENDER; HEALTH CARE ACCESS; HEALTH INSURANCE; HETEROSEXUALITY; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MALE HOMOSEXUAL; MORBIDITY; NONHUMAN; PATIENT CARE; POVERTY; PRIORITY JOURNAL; RACE; STIGMA; UNITED STATES; VIRUS TRANSMISSION;

AGE FACTORS; BENCHMARKING; ETHNIC GROUPS; FEMALE; HEALTH SERVICES; HIV; HIV INFECTIONS; HUMANS; MALE; MINORITY GROUPS; SEX FACTORS; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 79953772320     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq044     Document Type: Article

References (31)

1. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA 2008; 300:520-9.
2. El Sadr WM, Mayer KH, Hodder SL. AIDS in America\forgotten but not gone. N Engl J Med 2010; 362:967-70.
3. Centers for Disease Control and Prevention (CDC). Estimates of new HIV infections in the United States, http://www.cdc.gov/hiv/topics/surveillance/ resources/factsheets/incidence.htm. Accessed 28 February 2010.
4. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009; 373:48-57.
5. Centers for Disease Control and Prevention (CDC). HIV prevalence estimates-United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:1073-6.
6. Centers for Disease Control and Prevention (CDC). New estimates of US HIV prevalence, 2006. http://www.cdc.gov/hiv/topics/surveillance/resources/ factsheets/prevalence.htm. Accessed 28 February 2010.
7. Centers for Disease Control and Prevention (CDC). HIV/AIDS Surveillance Report, 2007. http://cdc.gov/hiv/topics/surveillance/resources/reports/ 2007report/pdf/2007SurveillanceReport.pdf Accessed 28 February 2010.
8. Centers for Disease Control and Prevention (CDC). Subpopulation estimates from the HIV incidence surveillance system\United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:985-9.
9. Centers for Disease Control and Prevention (CDC). HIV/AIDS among persons aged 50 and older. http://www.cdc.gov/hiv/topics/over50/resources/factsheets/ over50.htm. Accessed 28 February 2010.
10. Sanchez T, Finlayson T, Drake A, et al. Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors-United States, National HIV Behavioral Surveillance System: men who have sex with men, November 2003-April 2005. MMWR Surveill Summ 2006; 55:1-16.
11. Campsmith ML, Rhodes PH, Hall HI, Green TA. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr 2010; 53:619-24.
12. Althoff KN, Gange SJ, Klein MB, et al. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis 2010; 50:1512-20.
13. Keruly JC, Moore RD. Immune status at presentation to care did not improve among antiretroviralnaive persons from 1990 to 2006. Clin Infect Dis 2007; 45:1369-74. (Pubitemid 351411916)
14. Branson BM, Handsfield HH, Lampe MA, et al. Revised recom-mendations for HIV testing of adults, adolescents, and pregnant women in healthcare settings. MMWR Recomm Rep 2006; 55:1-17.
15. Teshale E, Kamimoto L, Harris N, Li J, Wang H, McKenna M. Esti-mated number of HIV-infected persons eligible for and receiving HIV antiretroviral therapy, 2003\United States. Presented at: Program and Abstracts of the 12th Conference on Retroviruses and Opportunistic Infections; 22-25 February 2005; Boston, MA. Abstract 167.
16. Cunningham WE, Sohler NL, Tobias C, et al. Health services utilization for people with HIV infection: comparison of a population targeted for outreach with the US population in care. Med Care 2006; 44:1038-47. (Pubitemid 44674036)
17. Seekins D, Stryker R, Lovvoll V. Estimation ofthe size andtreatment status of the HIV population in the United States. Presented at: 48th Annual Meeting ofIDSA21-24 October 2010; Vancouver, WA. Presentation 1064.
18. Mehta SD, Hall J, Greenwald JL, Cranston K, Skolnik PR. Patient risks, outcomes, and costs ofvoluntary HIV testing at five testing sites within a medical center. Public Health Rep 2008; 123:608-17.
19. Jain CL, Wyatt CM, Burke R, Sepkowitz K, Begier EM. Knowledge of the Centers for Disease Control and Prevention's 2006 routine HIV testing recommendations among New York City internal medicine residents. AIDS Patient Care STDS 2009; 23(3);167-76.
20. Goetz MB, Hoang T, Henry SR, et al. Evaluation of the sustainability of an intervention to increase HIV testing. J Gen Intern Med 2009; 24:1275-80.
21. Mimiaga MJ, Reisner SL, Bland S, et al. Health system and personal barriers resulting in decreased utilization of HIV and STD testing services among atrisk black men who have sex with men in Massa-chusetts. AIDS Patient Care STDS 2009; 23:825-35.
22. Torian LV, Wiewel EW, Liu KL, Sackoff JE, Frieden TR. Risk factors for delayed initiation of medical care after diagnosis of human immuno-deficiency virus. Arch Intern Med 2008; 168:1181-7. (Pubitemid 351831401)
23. Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS 2009; 23:41-9.
24. Gardner LI, Metsch LR, Anderson-Mahoney P, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS 2005; 19:423-31. (Pubitemid 40446189)
25. Ehrenkranz PD, Pagan JA, Begier EM, Linas BP, Madison K, Armstrong K. Written informedconsent statutes and HIV testing. Am J Prev Med 2009; 37:57-63.
26. April MD, Walensky RP, Chiosi J, Paltiel D. The survival cost of optin consent for HIV testing. Presented at: Infectious Diseases Society of America (IDSA); 29 October-1 November 2009; Philadelphia, PA. Presentation 1254.
27. Centers for Disease Control and Prevention (CDC). HIV/AIDS among African Americans. http://www.cdc.gov/hiv/topics/aa/resources/fact-sheets/aa.htm. Accessed 28 February 2010.
28. Centers for Disease Control and Prevention (CDC). HIV/AIDS and women. http://www.cdc.gov/hiv/topics/women/index.htm. Accessed 28 February 2010.
29. Hader SL, Smith DK, Moore JS, Holmberg SD. HIV infection in women in the United States: status at the Millennium. JAMA 2001; 285:1186-92. (Pubitemid 32198485)
30. Centers for Disease Control and Prevention (CDC). HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men\five US cities, June 2004-April 2005. MMWR Morb Mortal Wkly Rep 2005; 54:597-601.
31. Centers for Disease Control and Prevention (CDC). HIV/AIDS among Hispanics/Latinos. http://www.cdc.gov/hiv/hispanics/index.htm. Ac-cessed 28 February 2010.